Smartee's Manufacturing Partnership Signals Clear Aligner Consolidation
Event summary
- Smartee Denti-Technology reached 100,000 cases utilizing its GS Mandibular Repositioning technology in 2025.
- The company launched a 100,000-square-meter intelligent manufacturing campus to expand production capacity.
- Smartee entered a strategic partnership with Straumann Group to manufacture ClearCorrect aligners in EMEA and APAC markets.
- Smartee introduced two new products: Smartee Sleep Aligner (for sleep apnea) and Smartee Live 3D (an AI-powered treatment planning tool).
- The company expanded its global footprint with a UK subsidiary and a European clinical support center in Stoke-on-Trent.
The big picture
Smartee's rapid expansion and partnership with Straumann highlight the ongoing consolidation within the digital orthodontics market. The company's focus on manufacturing scale and AI-driven efficiency positions it to capitalize on the growing demand for clear aligner treatments globally. The entry into the sleep apnea market represents a strategic diversification, but also introduces new regulatory and clinical challenges.
What we're watching
- Competitive Landscape
- The Straumann partnership suggests Smartee is positioning itself as a contract manufacturer, which could intensify competition within the clear aligner space as other players seek similar outsourcing options.
- Clinical Adoption
- The pace at which the 100,000-case milestone translates into broader adoption of mandibular repositioning techniques will depend on continued publication of positive clinical outcomes and acceptance by orthodontists.
- Regulatory Scrutiny
- As Smartee expands its sleep apnea device offerings, increased regulatory scrutiny of these devices, particularly regarding efficacy and patient safety, could impact growth and market access.
Related topics